Cytek Biosciences Inc (CTKB)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
734,405,000
EV to revenue ratio (TTM)
2.432
EV to ebitda
222.69
Financial Performance
Revenue (TTM)
206,709,000
Gross profit (TTM)
107,230,000
EBITDA
-39,761,000
Profitability
Operating margin (TTM)
-29.50%
Profit margin
-39.00%
Return on assets (TTM)
-6.31%
Return on equity (TTM)
-23.00%
Per Share Metrics
Revenue per share (TTM)
1.61
EPS
-0.63
Diluted EPS (TTM)
-0.63
Book value
2.48
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
370.37
PEG ratio
Price to sales ratio (TTM)
3.553
Price to book ratio (TTM)
2.293
Growth
Quarterly earnings growth (YoY)
5.60%
Quarterly revenue growth (YoY)
73.50%
Analyst Sentiment
Strong buy
1
Buy
1
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.186